Geode Capital Management, LLC Igm Biosciences, Inc. Transaction History

Geode Capital Management, LLC

$1.24 Trillion
Q1 2025

A detailed history of Geode Capital Management, LLC transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 425,660 shares of IGMS stock, worth $540,588. This represents 0.0% of its overall portfolio holdings.

Number of Shares

425,660

Previous 409,133 4.04%

Holding current value

$540,588

Previous $2.5 Million 80.43%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$1.15 - $6.8 $19,006 - $112,383	16,527 Added 4.04%	425,660 $489,000
Q4 2024 Feb 12, 2025	BUY	$6.05 - $17.83 $80,670 - $237,745	13,334 Added 3.37%	409,133 $2.5 Million
Q3 2024 Nov 12, 2024	BUY	$6.28 - $17.68 $176,581 - $497,126	28,118 Added 7.65%	395,799 $6.55 Million
Q2 2024 Aug 09, 2024	BUY	$6.51 - $11.47 $206,210 - $363,323	31,676 Added 9.43%	367,681 $2.53 Million
Q1 2024 May 13, 2024	BUY	$8.68 - $17.36 $81,149 - $162,298	9,349 Added 2.86%	336,005 $3.24 Million
Q4 2023 Feb 13, 2024	BUY	$3.94 - $8.79 $134,448 - $299,949	34,124 Added 11.67%	326,656 $2.71 Million
Q3 2023 Nov 13, 2023	BUY	$6.66 - $10.64 $480,285 - $767,303	72,115 Added 32.72%	292,532 $2.44 Million
Q2 2023 Aug 11, 2023	BUY	$8.86 - $14.0 $198,109 - $313,040	22,360 Added 11.29%	220,417 $2.03 Million
Q1 2023 May 15, 2023	BUY	$13.74 - $25.76 $59,178 - $110,948	4,307 Added 2.22%	198,057 $2.72 Million
Q4 2022 Feb 13, 2023	BUY	$15.45 - $26.02 $165,855 - $279,324	10,735 Added 5.87%	193,750 $3.3 Million
Q3 2022 Nov 14, 2022	SELL	$15.42 - $27.01 $211,176 - $369,901	-13,695 Reduced 6.96%	183,015 $4.16 Million
Q2 2022 Aug 12, 2022	SELL	$13.27 - $25.5 $233,180 - $448,086	-17,572 Reduced 8.2%	196,710 $3.55 Million
Q1 2022 May 13, 2022	BUY	$13.42 - $29.73 $927,335 - $2.05 Million	69,101 Added 47.6%	214,282 $5.73 Million
Q4 2021 Feb 11, 2022	SELL	$27.59 - $66.39 $226,734 - $545,593	-8,218 Reduced 5.36%	145,181 $4.26 Million
Q3 2021 Nov 12, 2021	BUY	$65.76 - $90.65 $551,726 - $760,553	8,390 Added 5.79%	153,399 $10.1 Million
Q2 2021 Aug 13, 2021	BUY	$57.98 - $96.6 $518,515 - $863,893	8,943 Added 6.57%	145,009 $12.1 Million
Q1 2021 May 12, 2021	BUY	$71.56 - $121.23 $1.24 Million - $2.1 Million	17,340 Added 14.61%	136,066 $10.4 Million
Q4 2020 Feb 12, 2021	SELL	$47.41 - $115.03 $70,735 - $171,624	-1,492 Reduced 1.24%	118,726 $10.5 Million
Q3 2020 Nov 13, 2020	SELL	$43.0 - $84.01 $1.75 Million - $3.42 Million	-40,685 Reduced 25.29%	120,218 $8.87 Million
Q2 2020 Aug 13, 2020	BUY	$51.3 - $75.21 $481,399 - $705,770	9,384 Added 6.19%	160,903 $11.7 Million
Q1 2020 May 14, 2020	BUY	$31.51 - $73.75 $912,687 - $2.14 Million	28,965 Added 23.63%	151,519 $8.51 Million
Q4 2019 Feb 13, 2020	BUY	$17.25 - $49.51 $2.11 Million - $6.07 Million	122,554 New	122,554 $4.68 Million

Others Institutions Holding IGMS

# of Institutions

Shares Held

15.8M

Call Options Held

26.8K

Put Options Held

800

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $36.8M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Igm Biosciences, Inc. Transaction History